Current status and development of hematopoietic stem cell transplantation in China: a report from Chinese Hematopoietic Stem Cell Transplantation Register Group.

作者
Lan‐Ping Xu,Xiao‐Jun Huang
出处
期刊:PubMed [National Institutes of Health]
卷期号:124 (16): 2548-55 被引量:7
标识
摘要

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has three decades history in China. During these periods, the number of HSCT has been increasing, donor and stem cell sources were expanded, indication of diseases and patients for HSCT extended. Forty-two HSCT units offered their data 1–6 times from July 2007 to June 2010. The annual increase rates were 8.8% to 10.8%. Matched sibling donor is 41%, mismatched related/haploidentical donor is 24%, unrelated volunteer donor is 16%, and umbilical cord blood is 2%. The indications of major disease entities are acute myeloid leukemia (AML, 35%), acute lymphobastic leukemia (ALL, 25%), chronic myeloid leukemia (CML, 21%), and myelodysplastic syndrome (MDS, 8%). The different opinions on the indication of HSCT were supported by some trials, matched/haploidentical HSCT fit for middle or high risk ALL and AML in first complete remission (CR1), the international prognosis score system (IPSS) — middle-II/high risk MDS, CML in advanced stage and so on, when patients have no matched sibling donor. In the Peking University Institute of Hematology, Peking University People's Hospital, haploidentical HSCT has received a comparable result to matched simbling donor HSCT and unrelated matched donor HSCT; we suggest haploidentical donor might be a routine alternative donor for high-risk patents who need an urgent HSCT without matched related donor in special center.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Naming完成签到 ,获得积分10
刚刚
刚刚
Orange的应助被合适的咖啡采纳,获得10
1秒前
1秒前
柳絮书生完成签到,获得积分10
1秒前
1秒前
1秒前
Ran完成签到 ,获得积分0
1秒前
limin完成签到,获得积分10
1秒前
小魏小魏发布了新的文献求助10
2秒前
shanhe完成签到 ,获得积分10
2秒前
Rafli发布了新的文献求助10
2秒前
2秒前
jayus发布了新的文献求助10
3秒前
orixero的应助被风车车采纳,获得20
3秒前
3秒前
Dylan完成签到,获得积分10
3秒前
3秒前
3秒前
chenchen发布了新的文献求助10
3秒前
3秒前
3秒前
3秒前
汉堡包的应助被HSTrigger采纳,获得10
4秒前
4秒前
嗯呐发布了新的文献求助10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
4秒前
科目三的应助被科研通管家采纳,获得10
4秒前
脑洞疼的应助被科研通管家采纳,获得30
5秒前
大个的应助被科研通管家采纳,获得10
5秒前
情怀的应助被科研通管家采纳,获得10
5秒前
Maestro_S的应助被科研通管家采纳,获得10
5秒前
myz发布了新的文献求助10
5秒前
5秒前
JackieLiu的应助被科研通管家采纳,获得30
5秒前
5秒前
英俊的铭的应助被科研通管家采纳,获得10
5秒前
6秒前
无花果的应助被科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182352
求助须知:如何正确求助?哪些是违规求助? 9571930
关于积分的说明 21820825
捐赠科研通 7778861
什么是DOI,文献DOI怎么找? 3433657
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479703